| Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States | | |
| Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma | | |
| Financial toxicity in ovarian cancer | | |
| Extra-abdominal Lymph Node Metastases as the First Presentation in Ovarian and Fallopian Tube Carcinomas | | |
| Recent Advances in Classification and Histopathological Diagnosis of Ovarian Epithelial Malignant Tumours | | |
| A prospective cross-sectional survey comparing patient and provider expectations regarding ovarian cancer prognosis | Gynecologic Oncology Reports | 2022 |
| Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer | International Journal of Gynecological Cancer | |
| Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers | Communications Biology | 2022 |
| Potential roles of claudin-3 and claudin-4 in ovarian cancer management | Journal of the Egyptian National Cancer Institute | 2022 |
| Metastasis in gynecological cancers | | 2022 |
| Perceptions and care Recommendations from Previvors: Qualitative analysis of female BRCA1/2 mutation Carriers' experience with genetic testing and counseling. | Gynecologic Oncology Reports | 2022 |
| Climacteric symptoms in postoperative patients among endometrial cancer, cervical cancer, and ovarian cancer: a cross-sectional study. | Supportive Care in Cancer | 2022 |
| Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma. | Journal of Ovarian Research | 2022 |
| Salpingo-Oophorectomy or Surveillance for Ovarian Endometrioma in Asymptomatic Premenopausal Women: a Cost-Effectiveness Analysis. | American Journal of Obstetrics and Gynecology | 2022 |
| Data_Sheet_1.pdf | | 2019 |
| Table_4.XLSX | | 2020 |
| Table_3.XLSX | | 2020 |
| Table_2.XLSX | | 2020 |
| Table_1.xlsx | | 2020 |
| Data_Sheet_3.PDF | | 2020 |
| Data_Sheet_2.PDF | | 2020 |
| Data_Sheet_1.PDF | | 2020 |
| Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience. | Annals of Surgical Oncology | 2022 |
| Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study. | BMC Cancer | 2021 |
| Trends in extent of surgical cytoreduction for patients with ovarian cancer | PLoS ONE | 2021 |
| Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study. | Journal of Obstetrics and Gynaecology Research | 2021 |
| Oncologic outcomes of fertility-sparing surgery in early stage epithelial ovarian cancer: a population-based propensity score-matched analysis. | Archives of Gynecology and Obstetrics | 2022 |
| Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer. | Advances in Therapy | 2022 |
| Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impact. | European Journal of Obstetrics, Gynecology and Reproductive Biology | 2022 |
| CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy. | Npj Systems Biology and Applications | 2022 |
| Aktuelle Aspekte zur operativen Therapie des primären Ovarialkarzinoms | Der Gynakologe | 2022 |
| Ovarian Carcinoma Presenting With a Large Cervical Mass. | Cureus | 2022 |
| Sensitive New Assay System for Serum Agglutinin-Reactive Ceruloplasmin That Distinguishes Ovarian Clear Cell Carcinoma from Endometrioma. | Analytical Chemistry | 2022 |
| An integrated approach to protein discovery and detection from complex biofluids | | |
| Breast cancer risk in mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer. | Gynecologic Oncology Reports | 2022 |
| Extracellular Vesicle Molecular Signatures Characterize Metastatic Dynamicity in Ovarian Cancer | Frontiers in Oncology | 2021 |
| Estimating the Financial Impact of Gene Therapy* | | |
| Tumors of the Female Reproductive Organs | | 2020 |
| Gynecologic Disorders in the Older Woman | | 2020 |
| Over kanserinin epidemiyolojisi ve genel sağ kalım özellikleri | Ege Tıp Dergisi | |
| Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program | Advances in Therapy | 2021 |
| Pretreatment with LCK Inhibitors Chemosensitizes Cisplatin-Resistant Endometrioid Ovarian Tumors | | |
| Adnexal Masses in Adolescents | Pediatric Annals | 2020 |
| Supervivencia de pacientes con cáncer epitelial de ovario en el Instituto Nacional de Cancerología, resultados a partir del registro hospitalario de cáncer, (2005-2014) | Revista Colombiana De Cancerología | 2019 |
| The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma | | |
| Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4 | International Journal of Gynecological Cancer | 2019 |
| Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer | World Journal of Clinical Oncology | 2019 |
| Cancers | Advances in Bioinformatics and Biomedical Engineering Book Series | 2019 |
| Gynecologic Disorders in the Older Woman | | 2019 |
| Epithelial Tumors of the Ovary | | 2018 |
| Survivorship of Gynecologic Malignancy | | 2017 |
| Management of Ovarian Cancer in the Elderly Population | Comprehensive Gynecology and Obstetrics | 2017 |
| Tumors of the Female Reproductive Organs | | 2017 |
| Survivorship of Gynecologic Malignancy | | 2016 |
| Tumors of the Female Reproductive Organs | | 2014 |
| Metronomic Chemotherapy in Gynecological Cancers | | 2014 |
| Energy metabolism and changes in cellular composition in ovarian cancer | Methods in Molecular Biology | 2013 |
| Metabolomic profiling of ovarian carcinomas using mass spectrometry | Methods in Molecular Biology | 2013 |
| Ovarian Cancer Relapse: Experimental Therapies | | 2013 |
| Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis | Reproductive Biology and Endocrinology | 2021 |
| Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancer | BMJ Open | 2021 |
| Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer | Oncotarget | 2017 |
| Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky | Southern Medical Journal | 2018 |
| Association between social support and post-traumatic stress disorder symptoms among Chinese patients with ovarian cancer: A multiple mediation model | PLoS ONE | 2017 |
| Feature Selection Using SEER Data for the Survivability of Ovarian Cancer Patients | Algorithms for Intelligent Systems | 2020 |
| Palliative Medicine in the Management of Ovarian Cancer | Comprehensive Gynecology and Obstetrics | 2017 |
| Label-free microfluidic enrichment of cancer cells from non-cancer cells in ascites | Scientific Reports | 2021 |
| Artificial intelligence-based image analysis can predict outcome in high-grade serous carcinoma via histology alone | Scientific Reports | 2021 |
| Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancer | International Journal of Gynecological Cancer | 2021 |
| Reliability, validity and important difference estimates for the NCCN-FACT Ovarian Symptom Index-18 (NFOSI-18) | Future Oncology | 2021 |
| Clinical significance of circulating tumor cell related markers in patients with epithelial ovarian cancer before and after adjuvant chemotherapy | Scientific Reports | 2021 |
| Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers | Drug Design, Development and Therapy | 2021 |
| Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumors | Journal of Ovarian Research | 2021 |
| The Pharmacological or Genetic Blockade of Endogenous Fatty Acid Synthesis Does Not Increase the Uptake of Exogenous Lipids in Ovarian Cancer Cells | Frontiers in Oncology | 2021 |
| The value of human epididymis 4, D-dimer, and fibrinogen compared with CA 125 alone in triaging women presenting with pelvic masses: a retrospective cohort study | Acta Obstetricia Et Gynecologica Scandinavica | 2021 |
| Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis | Frontiers in Oncology | 2021 |
| Feasibility of maturation of oocytes collected from patients with malignant ovarian tumors undergoing fertility preservation | International Journal of Gynecological Cancer | 2021 |
| An Overview of Ovarian Cancer: Molecular Processes Involved and Development of Target-based Chemotherapeutics | Current Topics in Medicinal Chemistry | 2021 |
| Incidence of and risk factors associated with lung metastases in newly diagnosed epithelial ovarian cancer with a look on prognosis after diagnosis: a population-based cohort study of the SEER database | Archives of Gynecology and Obstetrics | 2021 |
| Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature | Cancers | 2021 |
| Trends and racial disparities in aggressive end-of-life care for a national sample of women with ovarian cancer | Cancer | 2021 |
| Experiences of women with ovarian cancer during the COVID-19 pandemic: Examining intolerance of uncertainty and fear of COVID-19 in relation to psychological distress | Journal of Psychosocial Oncology | 2021 |
| PARP inhibitors in ovarian cancer: An overview of the practice-changing trials | Genes Chromosomes and Cancer | 2021 |
| Three Weeks Carboplatin/Paclitaxel versus Weekly Regimen in Egyptian Women Cohort Treated for Ovarian Carcinoma | Journal of Cancer Therapy | 2021 |
| A Review of Pharmacologic Management in the Treatment of Mesothelioma | Current Treatment Options in Oncology | 2021 |
| Outcomes after Fertility-sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature | Journal of Minimally Invasive Gynecology | 2021 |
| No signs of subclinical atherosclerosis after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers | Journal of Cardiology | 2021 |
| Fertility considerations prior to conservative management of gynecologic cancers | International Journal of Gynecological Cancer | 2021 |
| The Budget Impact of Including Rucaparib on a US Payer Formulary for the Treatment of Patients with Metastatic Ovarian Cancer | Pharmacoeconomics | 2021 |
| Imaging spectrum of mesenteric masses | Abdominal Radiology | 2020 |
| Functional Landscape of Common Variants Associated with Susceptibility to Epithelial Ovarian Cancer | Current Epidemiology Reports | 2020 |
| Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein-2 cell entry receptor | Journal of Medical Virology | 2020 |
| Racial and ethnic disparities in the overall survival of women with epithelial ovarian cancer in Florida, 2001-2015 | Cancer Causes and Control | 2020 |
| Impact of Rurality on Stage IV Ovarian Cancer at Diagnosis: A Midwest Cancer Registry Cohort Study | Journal of Rural Health | 2020 |
| PARP Inhibitors in Gynecologic Cancers: What Is the Next Big Development? | Current Oncology Reports | 2020 |
| Giant cystic brain metastasis from ovarian papillary serous adenocarcinoma: Case report and review of the literature | Interdisciplinary Neurosurgery: Advanced Techniques and Case Management | 2020 |
| miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling | Nature Communications | 2020 |
| State of the art and up-and-coming angiogenesis inhibitors for ovarian cancer | Expert Opinion on Pharmacotherapy | 2020 |
| Fertility-sparing treatment for early-stage epithelial ovarian cancer: Contemporary oncologic, reproductive and endocrinologic perspectives | Journal of Obstetrics and Gynaecology Research | 2020 |
| Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles | Cellular Oncology (Dordrecht) | 2020 |
| Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States | JAMA Network Open | 2020 |
| The investigation of T-cell receptor subtypes in ovarian cancer: effects on survival and prognostic factors | Journal of Obstetrics and Gynaecology | 2021 |
| Immune Characterization of Ovarian Cancer Reveals New Cell Subtypes With Different Prognoses, Immune Risks, and Molecular Mechanisms | Frontiers in Cell and Developmental Biology | 2020 |
| The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma | Gynecologic Oncology | 2020 |
| Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data | Cancer Medicine | 2020 |
| High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer | BMC Cancer | 2020 |
| First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research | Cancer Management and Research | 2020 |
| Mechanisms to increase cascade testing in hereditary breast and ovarian cancer: Impact of introducing standardized communication aids into genetic counseling | Journal of Obstetrics and Gynaecology Research | 2020 |
| Metastatic epithelial ovarian cancer to Meckel's cave with leptomeningeal spread at time of diagnosis | Gynecologic Oncology Reports | 2020 |
| Treatment of epithelial ovarian cancer | BMJ, The | 2020 |
| PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin | | 2020 |
| Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review | Abdominal Radiology | 2021 |
| Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells | OncoTargets and Therapy | 2020 |
| Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network | Journal of Clinical Pathology | 2021 |
| Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries | Cancer | 2020 |
| Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes | Clinical and Experimental Metastasis | 2020 |
| Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer | PLoS ONE | 2020 |
| Size threshold for follow-up of postmenopausal adnexal cysts: 1 cm versus 3 cm | Abdominal Radiology | 2020 |
| Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles | Oncogene | 2019 |
| PARP inhibitors in older patients with ovarian and breast cancer: Young International Society of Geriatric Oncology review paper | Journal of Geriatric Oncology | 2019 |
| Breast metastasis two years after pelvic surgery and adjuvant chemotherapy for serous ovarian cancer | Gynecological Endocrinology | 2019 |
| Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States | Pharmacoeconomics | 2019 |
| The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions | Cancer | 2019 |
| Ubiquitin-Proteasome Axis, Especially Ubiquitin-Specific Protease-17 () Gene Family, is a Potential Target for Epithelial-Mesenchymal Transition in High-Grade Serous Ovarian Cancer | Reproductive Sciences | 2019 |
| Proofs for implementation of higher HE4 and ROMA index cut-off values in ovarian cancer preoperative stratification | Journal of Obstetrics and Gynaecology | 2019 |
| Imaging in the pre-operative staging of ovarian cancer | Abdominal Radiology | 2019 |
| Ovarian Cancer: An Integrated Review | Seminars in Oncology Nursing | 2019 |
| Cervical, Ovarian and Endometrial Tumor Markers: Potential Clinical Value | Seminars in Ultrasound, CT and MRI | 2019 |
| Imaging and Differential Diagnosis of Ovarian Cancer | Seminars in Ultrasound, CT and MRI | 2019 |
| Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer | Journal of Ovarian Research | 2019 |
| Incidence of intraepithelial fallopian tube neoplasias in mexican women over 40 years of age that underwent elective hysterectomy | Journal of Ovarian Research | 2019 |
| Intraperitoneal (IP) port cytology after completion of primary therapy for advanced stage ovarian cancer: A novel approach to a "second look" | Gynecologic Oncology | 2019 |
| Nanoformulation of Talazoparib Delays Tumor Progression and Ascites Formation in a Late Stage Cancer Model | Frontiers in Oncology | 2019 |
| An aspirin a day keeps ovarian cancer at bay? | Expert Review of Anticancer Therapy | 2019 |
| Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis | Molecular and Cellular Proteomics | 2019 |
| Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives - a review | Journal of Ovarian Research | 2019 |
| Trends in the overall survival rates in women with advanced ovarian cancer in a single tertiary centre in New Zealand | Australian and New Zealand Journal of Obstetrics and Gynaecology | 2019 |
| Epithelial Tumors of the Ovary | | 2019 |
| PET/CT for Evaluation of Ovarian Cancer | Seminars in Nuclear Medicine | 2019 |
| Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review | Journal of Ovarian Research | 2019 |
| A Call for Epidemiological Research on Myeloid-Derived Suppressor Cells in Ovarian Cancer: A Review of the Existing Immunological Evidence and Suggestions for Moving Forward | Frontiers in Immunology | 2019 |
| Novel Approaches to Ovarian Cancer Screening | Current Oncology Reports | 2019 |
| Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer | BMC Cancer | 2019 |
| Patterns of Relapse and Survival Analysis of Advanced Epithelial Ovarian Cancers Operated in a Tertiary Cancer Centre | Indian Journal of Gynecologic Oncology | 2019 |
| Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study | Cancer | 2019 |
| Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction | Cancer Treatment Reviews | 2018 |
| Maintenance treatment of recurrent ovarian cancer: Is it ready for prime time? | Cancer Treatment Reviews | 2018 |
| Trends and outcomes of women with synchronous endometrial and ovarian cancer | Oncotarget | 2018 |
| The effect of the type of dietary protein on the development of ovarian cancer | Oncotarget | 2018 |
| Ovarian mass-differentiating benign from malignant. Why the International Ovarian Tumour Analysis rules should be implemented in Australasia | Australasian Journal of Ultrasound in Medicine | 2018 |
